Point72 Hong Kong LTD Sangamo Therapeutics, Inc Transaction History

Point72 Hong Kong LTD

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$3.28 - $6.21 $84,125 - $159,274	25,648 Added 1081.74%	28,019 $116,000
Q1 2022 May 16, 2022	SELL	$5.23 - $7.82 $19,345 - $28,926	-3,699 Reduced 60.94%	2,371 $14,000
Q4 2021 Feb 14, 2022	BUY	$7.29 - $10.97 $44,250 - $66,587	6,070 New	6,070 $46,000
Q3 2021 Nov 15, 2021	SELL	$9.01 - $12.01 $105,552 - $140,697	-11,715 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$10.17 - $12.64 $116,121 - $144,323	11,418 Added 3844.44%	11,715 $140,000
Q1 2021 May 17, 2021	SELL	$10.88 - $17.05 $29,288 - $45,898	-2,692 Reduced 90.06%	297 $4,000
Q4 2020 Feb 16, 2021	BUY	$9.23 - $18.18 $27,588 - $54,340	2,989 New	2,989 $47,000
Q2 2019 Aug 14, 2019	SELL	$8.75 - $13.03 $1,373 - $2,045	-157 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$7.72 - $12.81 $609 - $1,011	79 Added 101.28%	157 $1,000
Q4 2018 Feb 14, 2019	BUY	$9.51 - $16.6 $741 - $1,294	78 New	78 $1,000
Q2 2018 Aug 14, 2018	SELL	$13.9 - $19.8 $8,645 - $12,315	-622 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$16.7 - $26.35 $10,387 - $16,389	622 New	622 $12,000
Q4 2017 Feb 14, 2018	SELL	$11.6 - $17.35 $823 - $1,231	-71 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$8.4 - $15.0 $596 - $1,065	71	71 $1,000

111

56.4M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $180M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.